Hexapeptide-2

Hexapeptide-2

Hexapeptide-2

Hexapeptide-2, or more commonly referred to as GHRP-6, is an α-melanocyte-stimulating hormone antagonist.

 

 

SKU: 198839 Kategoria:
Partekatu zure maitasuna

Hexapeptide-2, or more commonly referred to as GHRP-6, is an α-melanocyte-stimulating hormone antagonist. Inhibiting tirosinasa jarduera, it suppresses both the production and subsequent deposition of pigment; improving overall skin tone is one of its primary effects.

The incorporation of D-amino acids within its structure significantly enhances metabolic stability, along with strengthened receptor binding stability and affinity. Structurally similar to α-MSH itself, Hexapeptide-2 blocks this hormone’s ability to bind to its receptors – melanozitoa activity being the direct target inhibited.

As an equivalent of GHRP-6, pulsatile pituitary secretion of growth hormone is stimulated; protein synthesis, bone development (and all related repair processes), zauriak sendatzea, and enhancement of immune function are all positively influenced.

Sekuentzia

His-Trp-Ala-Trp-Phe-Lys or H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

CAS zenbakia

87616-84-0

Formula molekularra

C46H56N12O6

Pisu Molekularra

873.014

Hexapeptide-2 Related Research

1.Potential Therapeutic Applications

Promising cosmetological potential exists as a whitening agent or a therapeutic for various forms of hyperpigmentation disorders. The antagonistic properties also suggest broader potential uses: appetite stimulation, kakexia improvement, and modulation of inflammation.

2.Antagonizing the α-MSH signaling pathway

Competitive receptor binding is the key mechanism; reducing melanina synthesis is the direct outcome.

Effective skin lightening is the end result of this process. Appetite centers in the hipotalamoa may be influenced, with quality of life improvements for patients with cachexia or age-related loss of appetite being a valuable secondary benefit.

3.Promoting Pulsatile Growth Hormone Secretion

Synergistic enhancement of endogenous ghrelin and suppression of somatostatin are what drive the desired pulsatile release.

This physiological pattern of release is considered a more effective therapeutic approach to avoid desensitization.

4.Stimulating Tissue and Bone Repair

Increased levels of growth hormone and IGF-1 promote mitotic and anabolic jarduera, thereby stimulating tissue proliferation, bereizketa, and repair.

This accelerates the repair of soft tissue and bone, promotes fibroblast proliferation and collagen sintesia, and enhances wound healing.

Gainera, estimulatzen du osteoblast activity and bone matrix formation, which helps increase bone density, accelerate fracture healing, and combat age-related bone loss.

COA

HPLC

MS

Sekuentzia:

His-Trp-Ala-Trp-Phe-Lys or H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

CAS:

87616-84-0

M.W:

873.014 g/mol

Hasiera Bilatu Whatsapp Zerbitzuak Produktua